KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Return on Capital Employed (2016 - 2026)

Boston Scientific's Return on Capital Employed history spans 18 years, with the latest figure at 9.62% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 141.0% to 9.62% in Q1 2026 year-over-year; TTM through Mar 2026 was 9.62%, a 141.0% increase, with the full-year FY2025 number at 10.01%, up 158.0% from a year prior.
  • Return on Capital Employed hit 9.62% in Q1 2026 for Boston Scientific, roughly flat from 9.57% in the prior quarter.
  • Over the last five years, Return on Capital Employed for BSX hit a ceiling of 9.62% in Q1 2026 and a floor of 4.62% in Q1 2022.
  • Historically, Return on Capital Employed has averaged 7.4% across 5 years, with a median of 7.9% in 2023.
  • Biggest five-year swings in Return on Capital Employed: soared 410bps in 2022 and later rose 15bps in 2024.
  • Tracing BSX's Return on Capital Employed over 5 years: stood at 5.81% in 2022, then skyrocketed by 36bps to 7.9% in 2023, then rose by 2bps to 8.05% in 2024, then rose by 19bps to 9.57% in 2025, then increased by 0bps to 9.62% in 2026.
  • Business Quant data shows Return on Capital Employed for BSX at 9.62% in Q1 2026, 9.57% in Q4 2025, and 9.41% in Q3 2025.